Taro Pharmaceutical Industries (TARO)

Taro Pharmaceutical Industries Aktie (TARO) Neueste Nachrichten

Taro Pharmaceutical Industries (TARO) Scheduled to Post Quarterly Earnings on Monday - Defense World

Defense World

Moving Average Crossover Alert: Taro Pharmaceutical - Yahoo News UK

Yahoo News UK

Taro Pharmaceutical Industries (TARO) Scheduled to Post Quarterly Earnings on Monday - MarketBeat

MarketBeat

(TARO) Proactive Strategies - Stock Traders Daily

Stock Traders Daily

StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO) - MarketBeat

MarketBeat

Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.com - Defense World

Defense World

Taro Pharmaceutical Industries Third Quarter 2023 Earnings: Misses Expectations - Yahoo New Zealand News

Yahoo New Zealand News

Will Taro Pharmaceutical Industries Continue to Surge Higher? - Yahoo New Zealand News

Yahoo New Zealand News

Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates - Yahoo Canada Shine On

Yahoo Canada Shine On

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote FOR Taro Sun ... - Investing.com India

Investing.com India

Taro Pharmaceutical Industries (NYSE:TARO) Receives New Coverage from Analysts at StockNews.com - MarketBeat

MarketBeat

Taro Pharmaceutical Industries (NYSE:TARO) Research Coverage Started at StockNews.com - Defense World

Defense World

MRK: 3 A-Rated Pharma Stocks to Buy for Long-Term Growth - StockNews.com

StockNews.com

Taro Pharmaceutical Industries (NYSE:TARO) Stock Price Passes Above 200-Day Moving Average of $40.01 - Defense World

Defense World

Taro Pharmaceutical Industries (NYSE:TARO) Stock Price Passes Above 200-Day Moving Average of $40.01 - Defense World

Defense World

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS - PR Newswire

PR Newswire

TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC ... - Business Wire

Business Wire

Taro to hold meetings for approval of merger with Sun Pharmaceutical Industries - Drug Store News

Drug Store News

Taro Inks $36M Investor Deal Over Generics Price-Fixing - Law360

Law360

Urticaria Drug Market Data and In-Depth Analysis to 2030 | Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical ... - Currency News Centre

Currency News Centre

BMY: 3 A-Rated Pharma Stocks to Boost Your Bottom Line - StockNews.com

StockNews.com

Bausch, Sun's Taro Settle Patent Clash on Duobrii Psoriasis Drug - Bloomberg Law

Bloomberg Law

Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™ Diaper ... - PR Newswire

PR Newswire

Taro Expands Branded Over-the-Counter Portfolio in U.S. with the Launch of FeverAll® Liquid Oral Acetaminophen for ... - PR Web

PR Web

Sun Pharma to acquire 16.33% stake in US-based Surgimatix for $3 million - Business Standard

Business Standard

Generic pharmaceutical drugs direct purchasers $85M class action settlement - Top Class Actions

Top Class Actions

TARO Stock Quote Price and Forecast - CNN

CNN

Sun Pharma Q3 results today: What to expect from India’s top drug maker? - The Economic Times

The Economic Times

Sun Pharma Q3 preview: Consolidated PAT may rise 8% YoY amid moderate revenue growth - The Economic Times

The Economic Times

Sun Pharma share price rises 4% after strong set of earnings from Taro - CNBCTV18

CNBCTV18

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AMAM, HARP, JNPR, TARO - GlobeNewswire

GlobeNewswire

Taro to become wholly owned by Sun Pharma - Globes

Globes

Sun Pharma to complete Taro buyout after 17 years - The Times of India

The Times of India

Sun Pharmaceutical Shares Zoom On Buying Remaining Stake In Taro - Goodreturns

Goodreturns

Taro Announces Merger Agreement with Sun Pharma USA - English - Israel - English - PR Newswire

PR Newswire

Sun Pharma shares hit 52-week high on acquisition of second Israeli company - Business Today

Business Today

AZN: 3 Top-Rated Pharma Stock Picks to Consider in the New Year - StockNews.com

StockNews.com

The pharmaceutical landscape in occupied Palestine - Peoples Dispatch

Peoples Dispatch

Amicus (FOLD) Banks on Galafold, Overdependence a Concern

Zacks Investment Research

Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug

Zacks Investment Research

Procaps Group, S.A. (PROC) Q3 Earnings and Revenues Top Estimates

Zacks Investment Research

Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate

Zacks Investment Research

Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis

Zacks Investment Research

Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program

Zacks Investment Research

Taro (TARO) is on the Move, Here's Why the Trend Could be Sustainable

Zacks Investment Research

Sun Pharma raises offer to acquire 100% shares of US-arm Taro Pharma - Moneycontrol

Moneycontrol

US drops price-fixing case against former Taro Pharmaceutical executive - Reuters

Reuters

Global Acetazolamide Market and Competition Analysis, 2023-2028, Featuring Accord Healthcare, Heritage Pharma ... - Yahoo Finance

Yahoo Finance

Bayer, Janssen Sue Taro Over Xarelto Generic - Law360

Law360

How will the Israel-Hamas war impact pharma manufacturers? - Pharmaceutical Technology

Pharmaceutical Technology